Clinical Trial Update: Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for an orally administered Salmonella-based survivin vaccine in multiple myeloma. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Salmonella-based survivin vaccine

Snippet

Sponsor: Baylor College of Medicine | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED